Radiological Contrast Media:
The Present and the Future In the 1960s, therapeutic medicine benefited enormously from the development of new pharmacological products. Of the ten leading therapeutic products in 1967 (last available statistics), only two were among the ten leading products of 1962, and four were not even marketed in 1962 (Intercontinental Medical Statistics Ltd, quoted by the Association of British Pharmaceutical Industry 1970). Yet, in this decade of technological brilliance, there has been no major advance in the development of new radiological contrast media. There are many and diverse factors contributing to this scientific paradox, including medical, chemical, technical and commercial ones. The 1960s did, however, see considerable advances in our basic understanding of currently available contrast media, and our researches have indicated some guidelines along which progress will be made in the 1970s.
Intravascular Contrast Media
All modem radiological contrast media are salts of iodinated organic acids. Like all salts, they consist of a positively charged cation and a negatively charged anion. The organic acids (which provide the anions) have a structure based on a benzene ring, three hydrogen atoms of which are replaced by iodine atoms; the other three hydrogen atoms are replaced by simple side chains. These iodinated substituted benzoic acids are powerful acids and their salts are therefore completely dissociated or ionized in the solutions used as contrast media. The anions and cations available in currently obtainable contrast media are presented in Fig 1. Until very r&ently it was assumed that the toxicity of intravascular contrast medium depended essentially on its anion content, that is on its constituent iodinated acid, but since 1960 an increasing number of investigators have demonstrated in animal experiments that the cation content in intravascular contrast medium plays a major role in its toxicity.
The sodium salts have been demonstrated to be more toxic than the equivalent meglumine salts in carotid arteriography (e.g. Vosse 1960 , Fischer & Eckstein 1961 , Fischer & Cornell 1965 and in coronary arteriography (Gensini & di Giorgi 1964 , Porstimann 1965 . It is probable that the smaller sodium ion passes more readily through the capillary membrane than the larger meglumine ion. The permeability of the capillary All these media are salts. One ofthe cations occupies the space so labelled in the structuralformula to produce a salt. The small side chains under the different registered names ofthe media occupy the space labelledX in the structuralformula The increased toxicity of the sodium salts may be reduced by the addition of small quantities of calcium ions (Salvesen et al. 1967 ) but the sodium-calcium mixture is still apparently more toxic than the pure meglumine salts for carotid arteriography (Cornell & Fischer 1967) .
In solutions providing the same iodine content, sodium salts of contrast media produce less viscosity than meglumine salts of the same iodinated anion. Solutions of sodium salts (or sodium-meglune mixtures) are therefore used when very rapid delivery of contrast medium is required, for instance in angiocardiography and aortography.
There is no good evidence that slow intravenous injections (as for pyelography) of the sodium salts are more toxic than the equivalent meglumine salts. There may well be an advantage in using sodium salts for intravenous pyelography as Benness (1970) has shown that they produce less diuresis and therefore more contrasty pyelograms that the equivalent meglumine salts.
In the present state of knowledge, it would seem advisable to have available solutions of meglumine salts (for cerebral, coronary and peripheral angiography), solutions of sodium salts for intravenous pyelography, and mixtures of sodium and meglumine salts to provide solutions of acceptable toxicity and low viscosity for angiocardiography and aortography.
There is certainly an obvious need for basic research not only into new iodinated anions, but also for new cations that have the low toxicity of the meglumine salts and provide solutions of low viscosity like the sodium salts.
The Anions
Three iodinated acids are used in contrast media in the UK; diatrizoic acid (Hypaque, Urografin), iothalamic acid (Conray), and metrizoic acid Note that it is identical with meglumine iodipamide (Biligrafin) except that a hydrogen atom at C5 in each benzene ring ofmeglumine iodipamide is replaced by -CO-NH-CH3 ir meglumine iocarmate. Thefundamental iodinated acid in meglumine iodipamide is diatrizoic acid; in meglumine iocarmate it is iothalamic acid (Conray) (Triosil, Isopaque). They are very similar chemically (Fig 1) , the only difference being a relatively minor variation of one side chain. Pharmacologically these three iodinated ions have very similar qualities; they have about the same clinical toxicity. The diatrizoate salts are less soluble than equivalent iothalamate and metrizoate salts.
One of the reasons why there has been no major advance in the formulation of contrast media since 1955 (when diatrizoates were introduced) is the remarkable safety of the iodinated ions already available to us; 20-30 g of iodine can be injected into the heart in 2 secs with very little subjective reaction, usually only a hot flush due to generalized vasodilatation.
All intravascular contrast media are powerful vasodilators and this is responsible for much of the discomfort of arteriography and for some of the hmmodynamic responses to angiocardiography and aortography. Krovetz et al. (1967) investigated the cardiovascular responses in a series of dogs to rapid injections of solutions of varying osmolarity into the right and left side of the heart. They demonstrated that the resulting decrease in femoral artery pressure and the increase in pulmonary artery pressure were dependent on the osmolarity of the injected solution. Solutions of sodium chloride and glucose produced similar pressure changes to those produced by solutions of contrast media (diatrizoates) of equal osmolarity.
It has long been established that all hypertonic solutions are powerful vasodilators when injected into arteries (Read et al. 1960) . It would therefore seem reasonable to anticipate that a contrast medium solution that had a lower osmolarity for any given iodine content would cause less vasodilatation and fewer htmodynamic responses when injected into the bloodstream. The opportunity to investigate this hypothesis in the field of contrast media occurred when iocarmic acid was synthesized. locarmic acid is formed when 2 molecules of iothalamic acid (Conray) deprived of an acetyl group are linked by a bridge of adipic acid (Fig 2) . It has been called 'Conray Dimer', but it is not strictly a polymer as it is not composed only of 2 molecules of Conray but has the additional adipic acid. It is a dibasic acid and therefore combines with 2 cations. One molecule of meglumine iocarmate (Dimer X; Laboratoires Andr6 Guerbet, Paris) will dissociate in solution to give 3 ions, namely one iocarmate (containing 6 atoms of iodine) and 2 meglumine cations.
One molecule of meglumine iocarmate has the same iodine content (6 atoms) and almost the same molecular weight as 2 molecules of meglumine iothalamate (Fig 3) .
Osmolarity of a solution is a measure of the number of dissolved particles (ions, molecules or aggregates) in each litre of solution. Osmolarity is expressed by the formula C-x osmoles per litre, where C=Concentration in grams per litre, n= number of individual particles into which each molecule dissociates, and M==molecular weight of the total molecule.
Meglumine iothalamate (Conray) has a molecular weight of 809 and is dissociated into 2 ions in solution. The calculated osmolarity of 60% solution of meglumine iothalamate (Conray 280) is therefore -0=x 148 osmoles per litre (Fig 3) .
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Meglumine iocarmate (Dimer X) has a molecular weight of 1644 and dissociates into 3 ions in solution. A 60% solution of meglumine iocarmate (Dimer X) has the same iodine content, It is therefore apparent that for the same iodine concentration (280 mg/ml), meglumine iocarmate (Dimer X) has a considerably lower osmolarity than meglumine iothalamate; the actual ratio is 1-094 1 =0 74. It is to be expected therefore that meglumine iocarmate would be a less active vasodilator than an equivalent solution of meglumine iothalamate. Animal Evaluation A series of experiments were conducted at Stanford University Medical Center (Grainger & Wexler 1969, unpublished) to test this hypothesis. A series of dogs was anmsthetized, the femoral artery catheterized and injections of 2 ml of various solutions made into it. An electromagnetic flow meter was placed round the artery downstream and the variation in flow rate was determined. All the contrast medium solutions had the same iodine content (325 mg/ml). Fig 4 shows a typical experiment from which the following deductions can be made: Sodium chloride 0-9 % produced no change in femoral artery flow rate. Sodium chloride 4-95% produced a great increase in femoral blood flow (100% increment). Sodium iothalamate 32-5% (which has the same osmolarity as 4 95 % sodium chloride) produced an identical increment (100%) in femoral artery flow rate. Sodium iocarmate solution (providing the same iodine -1 245 content as the sodium iothalamate solution) produced much less (approximately 50%) increase in flow rate. Meglumine iothalamate produced rather less increase in femoral artery blood flow than sodium iothalamate providing the same iodine content. Meglumine iocarmate produced much less increase in femoral artery flow rate than either meglumine iothalamate or sodium iocarmate. All solutions provided the same iodine content.
The increase in femoral artery flow rate was due to distal vasodilatation produced by the injections into the femoral artery. There was no significant change in cardiac output due to the small volumes injected. The experiment therefore confirms (1) that meglumine salts produce less vasodilatation than equivalent sodium salts, and (2) that both sodium and meglumine iocarmate produce less vasodilatation than sodium and meglumine iothalamate, in solutions providing the same iodine content. This suggests that iocarmate salts (or some similar salt which provides solutions of low osmolarity) may be suitable for clinical angiography.
Bjork et al. (1969) have used a similar 'dimeric' compound (named Ph DZ 59B) which is the meglumine salt of a dimeric form of metrizoic acid. In double blind trials of peripheral and carotid arteriography and central angiocardiography, they found that almost all patients much preferred the new product (the metrizoate dimer) to metrizoate or diatrizoate salt solutions providing the same iodine content. This suggests that the new large molecule 'dimeric' forms of contrast media may prove a significant radiological advance.
Lumbar Radiculography
In Scandinavian and some European countries, water-soluble myelographic agents have been used for several years; they have not been adopted in England or America because of their irritation of the meninges and spinal cord. It is, however, generally agreed that water-soluble myelography and radiculography provide diagnostic evidence which is not available with oil (Myodil) myelography.
Methiodal (sodium iodomethanesulphonate) is the water-soluble product generally used but it requires a spinal anesthetic in order to eliminate the pain and spasms which occur without the an&esthesia. Its irritant qualities are partly due to its hypertonicity. A solution of another contrast medium which provided the same iodine content but had a lower osmolarity might well prove to be better tolerated in the subarachnoid space.
Dimer X is a 60 % solution of meglumine iocarmate (Laboratoires Guerbet, Paris). It has been used for lumbar radiculography in over with amputation ofits subarachnoid root sheath 4,000 patients with marked success (Gonsette 1971) . In a limited trial personally conducted, the excellent tolerance of Dimer X in the lumbar subarachnoid space has been fully confirmed (Grainger et al. 1971 ). The examination is quite painless, there have been no muscle spasms, and therefore spinal an.Tsthesia is definitely not required. The quality of the lumbar radiculograms with Dimer X is far superior to that produced by Methiodal. Dimer X contains much more iodine (28% compared to 10% in Methiodal) and is more viscous and heavier, thereby permitting improved gravitational control. Like Methiodal, Dimer X is absorbed from the CSF in a few hours and is excreted by the kidneys.
It seems likely that lumbar water-soluble radiculography may be increasingly practised in this country now that a much safer contrast medium has been formulated. At present, Dimer X is not recommended for myelography (as opposed to lumbar radiculography) as it may prove irritant to the spinal cord. Gonsette (1971) has, however, performed many cerebral ventriculograms with the product and considers it no more dangerous than Myodil ventriculography ( Fig 5) . Dimer X ventriculograms certainly provide far more anatomical detail than when the oily Myodil is used (Fig 6) . Assessment ofContrast Media for Carotid Arteriography Two new sophisticated tests of neurotoxicity of contrast agents have been recently devised by Gonsette & Andre-Balisaux (1967) and they promise to become the most effective techniques yet available. They assess the effect of contrast media on the blood-brain barrier, the permeability of which increases when exposed to toxic agents. Gonsette uses the guinea-pig as the experimental animal.
(1) Broman & Olsson (1956) developed the trypan blue method of assessment of the bloodbrain barrier. Following cerebral arteriography, a suspension of trypan blue was injected into the carotid artery and the degree of subsequent blue staining of the brain indicated the increase in permeability which the contrast medium had produced. Gonsette uses radioactive 32p solutions instead of trypan blue and measures the subsequent staining of the brain by autoradiography of slices of the brain.
(2) Gonsette has demonstrated and quantitated electron microscopic changes in the brain after carotid arteriography. The degree of extracellular cedema and swelling of the astrocytes increases with the toxicity ofthe contrast medium.
These two new techniques may well become standard methods for the assessment of contrast media for carotid arteriography.
Particulate Contrast Media It would be a major advance in cardiovascular radiology if the concentration of a contrast medium could be assessed by counting the number of particles. Mygind of Denmark (1966) has prepared gelatin spheres (diameter 1 mm) which can be impregnated with standard contrast media (for instance Hypaque or Conray). These contrast-loaded gelatin spheres dissolve within 5 secs of intravascular injection so that they do not cause embolization. Mygind & Sovak (1968) have successfully quantitated experimental mitral incompetence in the dog by particle counts on individual cine frames of the contrast spheres which refluxed into the left atrium after left ventricular injection. Although there are considerable problems regarding storage of Mygind's gelatin spheres, it is quite likely that his concept of particulate contrast media may provide a new dimension in the angiographic assessment of hmmodynamic situations.
Superselective Angiography Selectivity of injection may be obtained anatomically by introducing the catheter into 2nd or 3rd degree branches of a major artery. Superselective angiography provides much better angiographic detail and contrast than less selective injections into larger arteries. Improved catheter design and manipulation and increasing technical skill is permitting superselective angiography of many different organs, for instance pancreas, bowel and brain. The magnetically controlled pod catheter developed by Frei at the Weitzman Institute, Israel (Frei et al. 1968 ), and employed experimentally by Hilal at the Presbyterian Hospital, New York (Z Hilal 1970, personal communication) provides a new dimension of catheter control and man(ruvrability.
Pharmacological selectivity of angiography was introduced by Abrams (1964) using adrenaline injected into the renal artery; 10-20 mg of adrenaline causes complete cessation of renal blood flow for 60 seconds by producing severe contraction of the normal intrarenal arteries. Abnormal renal arteries, particularly tumour vessels, do not so react and the contrast medium is diverted from normal renal tissue to the tumour, producing much improved angiographic visualization (Fig 7) .
The pharmacological control of selective arteriography promises to develop into a major diagnostic advance. Pharmacologically active agents such as ,-adrenergic blockers and bradykinin have also been used successfully to modify vasomotor control during selective arteriography; specific organ stimulators such as secretin (for the pancreas) cause selective vasodilatation, improving arteriographic visualization of the specific organ.
Contrast Medium Flow Rate
The flow rate of contrast medium injected through a catheter can be considerably increased by the addition of minute quantities of long-chain polymers (for example carboxy methyl cellulose, dextrans, Polyox). The physical principle involved was developed through naval research which demonstrated a marked reduction in friction drag after the painting of the hulls of ships and submarines with similar substances. Bove et al. (1969) have shown that the addition of these agents can improve by 30-40% the flow rate of contrast medium solution through catheters under turbulent flow conditions. Perhaps the addition of these polymers to solutions of large molecular contrast media (such as the dimers) may provide a useful increase in flow rate to compensate for their greater viscosity. Radiopaque Elements It is surprising that, seventy years after R6ntgen's discovery, the only elements in routine use for producing radiological contrast are barium and iodine. Two promising new radiopaque elements are iron and tantalum.
Frei and Pajewsky (Frei et al. 1968 ) developed magnesium ferrite, a new ferromagnetic radiopaque contrast medium. This agent can be used to replace barium sulphate for examination of the alimentary tract. The passage of the magnesium ferrite through the bowel can be controlled by an externally applied magnet and it can therefore be arrested in any particular segment which it is desired to examine.
Tantalum (a metal much used in surgery) can be prepared in finely powdered form (2-5,m) which can be insufflated and deposited on mucous membranes (Nadel et al. 1968 ). It is especially effective in bronchography, where it produces high quality fine-line bronchograms demonstrating bronchi down to 1 mm diameter, without impairment of respiratory function. Tantalum powder may become a very effective bronchographic medium, perhaps best insufflated by endotracheal or endobronchial catheter. Finely powdered tantalum also produces extreme quality mucosal patterns of other viscera (for example bladder, cesophagus, stomach) without the disturbing effect of intraluminal contrast material. It has already proved of considerable use in animal research projects and is now being cautiously evaluated in the human.
Conclusion
The above-mentioned aspects indicate some of the areas in which real progress may be made in the next decade. It is hoped that some of this basic work started in the 1960s will mature to fruition in the 1970s. If this promise is fulfilled, it will provide the first major breakthrough in the field ofcontrast media since the early 1950s.
Selecting the Next Neuroradiological Investigation with the Help ofa Computer [Summary]
The present authors described in 1968 their method of using a computer to assist the diagnosis of intracranial tumours. There are two programs, the first offering the six most likely diagnoses in order of probability (out of a choice of about 180 permutations of pathology and precise position), the second suggesting which neuroradiological investigation might be most helpful as a next step.
The success achieved over the last 100 cases can be summarized as follows: the patients are first clinically divided into three groups: Group 1, perisellar tumours (21 cases); Group 2, other supratentorial tumours (54 cases); Group 3, juxtaand infra-tentorial tumours (25 cases). A 30% overall success in predicting a totally correct diagnosis (type and position of tumour) was achieved. In 71 % the correct position was predicted within the first three choices, and in 48 % both correct position and pathology.
Prediction of pathology in Groups I and 2 was probably better than could be achieved by the unaided radiologist. Prediction of situation was slightly less good than the experienced radiologist might expect. Errors were as follows: Group 2 cases which were not after all tumours, 6; Group 2 cases in which 'jokers' (see below) displaced a partly or completely correct diagnosis out of the first three choices, 3; Group 2 cases in which the correct diagnosis was totally missed by a wide margin, 8 (15 %); Group 3 cases totally incorrect, 8; near misses, e.g. 'frontoparietal' for parietal or 'glioblastoma' for slightly less malignant glioma, 4.
'Jokets' arc rare tumours offered as diagnoses by the computer when data are scanty. They are soon recognized as irrelevant by the experienced worker.
In Group 1 cases, there was an 81 % success rate in predicting the correct diagnosis with the first three choices. Group 3 predictions were somewhat less successful because of the paucity of information in the program concerning vertebral angiography.
Analysis of the results of the second program provides interesting information about the usefulness of different investigations and is a novel tool for the radiologist. It shows, for instance, the great value of carotid angiography in posterior fossa cases. Analysis of the programs also shows a tendency, like the human tendency, to cloud the issue by overinvestigating a straightforward case. The object of diagnostic radiology is to obtain information about the internal anatomy of a patient. This is done by studying the image produced by an X-ray detector; we must, therefore, concentrate on the quality of that image and on the factors affecting it.
